Cover Image
市場調查報告書

AC Immune SA的產品平台分析

AC Immune SA - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224739
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
AC Immune SA的產品平台分析 AC Immune SA - Product Pipeline Review - 2015
出版日期: 2015年04月22日 內容資訊: 英文 29 Pages
簡介

AC Immune SA是總公司設置於瑞士的生物製藥企業。該公司正在進行針對老年癡呆症和其他結構病所用的疫苗,抗體治療藥,低分子藥等治療藥之藥物研發·開發。

本報告提供AC Immune SA 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

AC Immune SA 基本資料

  • AC Immune SA 概要
  • 主要資訊
  • 企業資料

AC Immune SA :R&D概要

  • 主要的治療範圍

AC Immune SA :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 轉出授權產品
    • 轉出授權產品/聯合治療模式

AC Immune SA :開發中產品概況

  • 臨床階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

AC Immune SA:藥物簡介

  • ACI-24
  • ACI-35
  • ACI-260
  • ACI-812
  • Small Molecule to Inhibit Alpha-Synuclein for Parkinson's Disease
  • Small Molecule to Inhibit Tau Protein for Alzheimer's Disease

AC Immune SA :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

AC Immune SA :最新的開發平台資訊

AC Immune SA :開發暫停中的計劃

AC Immune SA :開發中止的開發中產品

  • 開發中止的開發中產品簡介

AC Immune SA :企業理念

AC Immune SA :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06973CDB

Summary

Global Markets Direct's, 'AC Immune SA - Product Pipeline Review - 2015', provides an overview of the AC Immune SA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of AC Immune SA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of AC Immune SA including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of AC Immune SA's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the AC Immune SA's pipeline products

Reasons to buy

  • Evaluate AC Immune SA's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of AC Immune SA in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the AC Immune SA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of AC Immune SA and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of AC Immune SA
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of AC Immune SA and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • AC Immune SA Snapshot
    • AC Immune SA Overview
    • Key Information
    • Key Facts
  • AC Immune SA - Research and Development Overview
    • Key Therapeutic Areas
  • AC Immune SA - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • AC Immune SA - Pipeline Products Glance
    • AC Immune SA - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • AC Immune SA - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • AC Immune SA - Drug Profiles
    • ACI-24
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACI-35
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACI-260
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ACI-812
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Alpha-Synuclein for Parkinson's Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit Tau Protein for Alzheimer's Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • AC Immune SA - Pipeline Analysis
    • AC Immune SA - Pipeline Products by Target
    • AC Immune SA - Pipeline Products by Route of Administration
    • AC Immune SA - Pipeline Products by Molecule Type
    • AC Immune SA - Pipeline Products by Mechanism of Action
  • AC Immune SA - Recent Pipeline Updates
  • AC Immune SA - Dormant Projects
  • AC Immune SA - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • pirenzepine
  • AC Immune SA - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • AC Immune SA, Key Information
  • AC Immune SA, Key Facts
  • AC Immune SA - Pipeline by Indication, 2015
  • AC Immune SA - Pipeline by Stage of Development, 2015
  • AC Immune SA - Monotherapy Products in Pipeline, 2015
  • AC Immune SA - Out-Licensed Products in Pipeline, 2015
  • AC Immune SA - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • AC Immune SA - Phase I, 2015
  • AC Immune SA - Preclinical, 2015
  • AC Immune SA - Pipeline by Target, 2015
  • AC Immune SA - Pipeline by Route of Administration, 2015
  • AC Immune SA - Pipeline by Molecule Type, 2015
  • AC Immune SA - Pipeline Products by Mechanism of Action, 2015
  • AC Immune SA - Recent Pipeline Updates, 2015
  • AC Immune SA - Dormant Developmental Projects,2015
  • AC Immune SA - Discontinued Pipeline Products, 2015

List of Figures

  • AC Immune SA - Pipeline by Top 10 Indication, 2015
  • AC Immune SA - Pipeline by Stage of Development, 2015
  • AC Immune SA - Monotherapy Products in Pipeline, 2015
  • AC Immune SA - Out-Licensed Products in Pipeline, 2015
  • AC Immune SA - Pipeline by Top 10 Target, 2015
  • AC Immune SA - Pipeline by Top 10 Route of Administration, 2015
  • AC Immune SA - Pipeline by Top 10 Molecule Type, 2015
  • AC Immune SA - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top